News Briefs Verastem Secures $16 Million in Series A Financing for Novel Cancer Stem Cell Drugs VCJ Staff - 16 November 2010 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
